Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.400
0.00 (0.00%)
At close: May 22, 2026, 4:00 PM EDT
1.475
+0.075 (5.36%)
Pre-market: May 26, 2026, 4:00 AM EDT
Marker Therapeutics Employees
Marker Therapeutics had 5 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$709,334
Profits / Employee
-$2,179,343
Market Cap
23.34M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | 0 | - |
| Dec 31, 2024 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | -59 | -88.06% |
| Dec 31, 2022 | 67 | 11 | 19.64% |
| Dec 31, 2021 | 56 | 12 | 27.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Celularity | 123 |
| Werewolf Therapeutics | 39 |
| Longeveron | 38 |
| Sensei Biotherapeutics | 29 |
| Jasper Therapeutics | 22 |
| BriaCell Therapeutics | 16 |
| Cellectar Biosciences | 11 |
MRKR News
- 8 days ago - Marker Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Marker Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Marker Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Marker Therapeutics reports FY25 EPS (79c), two estimates (94c) - TheFly
- 2 months ago - Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results - GlobeNewsWire
- 2 months ago - Marker Therapeutics Earnings release: Q4 2025 - Filings
- 2 months ago - Marker Therapeutics Annual report: Q4 2025 - Filings
- 2 months ago - Marker Therapeutics Proxy statement: Proxy Filing - Filings